We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$10.6B
AUM Growth
-$234M
Cap. Flow
-$434M
Cap. Flow %
-4.08%
Top 10 Hldgs %
11.4%
Holding
561
New
183
Increased
121
Reduced
99
Closed
141

Sector Composition

Rank Sector Weight
1 Healthcare 17.9%
2 Technology 14.54%
3 Industrials 10.72%
4 Consumer Discretionary 10.71%
5 Consumer Staples 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTNT
326
DELISTED
Quotient Limited Ordinary Shares
QTNT
$3.67M 0.03%
11,840
-1,910
-14% -$729K
AEL
327
DELISTED
American Equity Investment Life Holding Company
AEL
$3.65M 0.03%
256,002
-1,712,393
-87% -$25.9M
FOMX
328
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$3.62M 0.03%
569,403
+11,554
+2% +$76.7K
FNF icon
329
Fidelity National Financial
FNF
$13.5B
$3.61M 0.03%
138,598
+26,473
+24% +$624K
VRNS icon
330
Varonis Systems
VRNS
$5B
$3.6M 0.03%
+449,631
New +$3.3M
APC
331
DELISTED
Anadarko Petroleum
APC
$3.5M 0.03%
65,823
-827,558
-93% -$41.9M
SAAS
332
DELISTED
inContact, Inc.
SAAS
$3.48M 0.03%
+251,425
New +$2.9M
PKY
333
DELISTED
Parkway, Inc.
PKY
$3.43M 0.03%
+204,907
New +$3.39M
TRU icon
334
TransUnion
TRU
$15.3B
$3.34M 0.03%
100,000
-698,996
-87% -$21.5M
OPCH icon
335
Option Care Health
OPCH
$3.56B
$3.31M 0.03%
+325,000
New +$3.32M
ZVRA icon
336
Zevra Therapeutics
ZVRA
$686M
$3.23M 0.03%
50,792
+24,861
+96% +$4.09M
FENX
337
DELISTED
Fenix Parts, Inc.
FENX
$3.21M 0.03%
816,567
+16,567
+2% +$70.1K
XXIA
338
DELISTED
Ixia
XXIA
$3.17M 0.03%
+323,237
New +$3.32M
GNRT
339
DELISTED
Gener8 Maritime, Inc.
GNRT
$3.06M 0.03%
478,536
+9,710
+2% +$68.9K
SLG icon
340
SL Green Realty
SLG
$3.99B
$3.06M 0.03%
29,644
+12,059
+69% +$1.19M
NVRO
341
DELISTED
NEVRO CORP.
NVRO
$3.05M 0.03%
41,367
+6,750
+19% +$458K
CSLT
342
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$3.04M 0.03%
766,568
-383,432
-33% -$1.5M
GD icon
343
General Dynamics
GD
$106B
$3.04M 0.03%
+21,794
New +$3.04M
AGNC icon
344
AGNC Investment
AGNC
$12.9B
$3M 0.03%
+151,299
New +$2.86M
ALKS icon
345
Alkermes
ALKS
$8.25B
$2.98M 0.03%
+68,947
New +$2.84M
NEWR
346
DELISTED
New Relic, Inc.
NEWR
$2.94M 0.03%
100,000
-124,700
-55% -$3.42M
CRVS icon
347
Corvus Pharmaceuticals
CRVS
$1.17B
$2.86M 0.03%
200,873
+18,545
+10% +$250K
INNL
348
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$2.81M 0.03%
510,972
+300,000
+142% +$2.46M
FAF icon
349
First American
FAF
$7.58B
$2.77M 0.03%
+68,997
New +$2.57M
AIV
350
Aimco
AIV
$383M
$2.7M 0.03%
459,304
-146,578
-24% -$811K

Similar funds

Alyeska Investment Group's Q2 2016 Portfolio in Review

As of Q2 2016, Alyeska Investment Group held 561 positions worth $10.6B, down 2.2% from $10.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alyeska Investment Group withdrew a net $434M in Q2 2016, closing 141 positions and reducing 99 holdings. Its most notable exit was Cisco, an estimated $151M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Alyeska Investment Group opened a new position in Baxter International worth $111M.

  • Alyeska Investment Group's largest Q2 2016 buy was Baxter International: 2,450,018 shares worth $111M.
  • Alyeska Investment Group added most to Whole Foods Market Inc in Q2 2016, an estimated $119M increase.
  • Alyeska Investment Group's biggest Q2 2016 reduction was Devon Energy, cutting an estimated $176M.
  • Alyeska Investment Group fully exited Cisco in Q2 2016, selling an estimated $151M.
  • Alyeska Investment Group's ten largest holdings make up 11% of its $10.6B portfolio in Q2 2016.
  • Alyeska Investment Group opened 183 new positions and closed 141 in Q2 2016.
  • Alyeska Investment Group's portfolio value fell 2.2% quarter-over-quarter to $10.6B.

Based on Alyeska Investment Group's 13F filing for Q2 2016, filed 15 Aug 2016.